MAPT and Alzheimer disease: To investigate the relationships with AD pathology, we focused on typical measures of Aβ- and tau-PET, which is a global cortical Aβ burden (in PREVENT-AD and DIAN) and entorhinal tau tracer uptake (in PREVENT-AD only).